Dr Pauline Yeo
is the Head of Regulatory Affairs & Quality Assurance in D3, A*STAR, Singapore. She obtained her PhD from the University of California, Riverside, USA. In D3, she is responsible for local regulatory submissions to the Health Sciences Authority and oversees international regulatory submissions working closely with Clinical Research Organisations. She has experience with regulatory filings in the USA, Canada, European Union and Australia comprising INDs, clinical trial applications and orphan drug applications.
As Head of Quality Assurance, she has implemented the Quality System in D3 to ensure compliance with quality and regulatory requirements. She has more than 15 years of industrial experience in innovative biotechnological and pharmaceutical companies in San Diego, California and in Singapore. She also has extensive experience in drug development supporting functions in Regulatory Affairs, Quality Assurance, Clinical Development, Preclinical Development and Analytical Development.